Garland Surgical

01/04/2026

https://www.linkedin.com/posts/ahf-podcast_from-idea-to-market-a-new-series-on-innovation-activity-7427335666193330176-FjfB?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAAQ014BGQlg8jt0tmG6NKi0GdJZV1QzzZI

27/02/2026

✴️ A NEW CHAPTER FOR GARLAND SURGICAL!

We’re proud to open an exciting new chapter in our journey: our novel, patented hip implant, previously known as MaltaHip, will now be called TriActiv Hip – a name that captures the tri‑axial engineering at the heart of the design, and our vision for enhanced mobility, stability, and durability in today’s active patients.

MaltaHip will always be part of our story. It represents our roots as a University of Malta spin‑out and the foundation that enabled us to secure early funding, clinical interest, and invaluable feedback from partners around the world. But as we ready ourselves for Series A investment, it’s clear our brand must reflect our momentum and ambition.

TriActiv Hip does exactly that. It aligns our identity with our engineering innovation and the clinical outcomes we’re building towards, especially in high‑performance markets where patient mobility matters most.

Alongside this launch, we’re unveiling a refreshed Garland Surgical identity – including a redesigned website – all crafted to express the energy, precision, and purpose behind TriActiv Hip.

What remains unchanged is our mission: to bring this breakthrough technology successfully to market, build robust clinical and commercial evidence, and create lasting value for patients, clinicians, and shareholders alike.

Wishing you all a wonderful weekend and we look forward to sharing our new look with you over the coming weeks....watch this space!

09/12/2025

A great article about the MaltaHip published by Health.MT - its great to have our message amplified in Malta and beyond!

Hip arthritis is one of the most debilitating conditions affecting older adults worldwide, and Malta is no exception.

10/10/2025

📢 Santander X UK Awards: Pitching Success!

Earlier this week Natalie delivered a 4 minute pitch about Garland and the in the first round of the virtual pitches for the Santander X UK Awards 2025. The presentation was watched and evaluated by 4 judges who had backgrounds in academia, investment and customer engagement. Following the pitch, Natalie and Simon then had 4 minutes of Q&A to help give the panel further context into the Garland proposition.

🎉 We heard yesterday evening that we have been successful and we have made it into the final 25 Start Ups from across the UK! We pitch again next week, with the final 9 Start Ups heading to London for the semi final, and the final 3 head to Milton Keynes for the final on 13th November.

As always we are taking it each step at a time, learning from the fantastic coaching that Santander X and the Oxentia Foundation are providing us with and trying to enjoy the moment although 4 minutes goes in the blink of an eye!

10/09/2025

🎉 The good news keeps on coming this week!

We are delighted to announce that Garland is a finalist in not one but two categories at the upcoming BioSeed !

➡️ Best Early Stage Medtech Company Award
➡️ The BioSeed One to Watch Award

The BioSeed awards are highly regarded and sought-after awards programme for life sciences, designed to celebrate innovation and outstanding achievement across all corners of the industry. The twelve award categories shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches to unmet clinical needs, outstanding company progression and the delivery of real-life, tangible results.

The independent external judging panel will now evaluate each entry in a rigorous assessment process, with the winners announced at the awards ceremony in London on 26th November.

Thank you to OBN UK Ltd for recognising us...let's go!

09/09/2025

📢 Exciting news to share - Garland has been shortlisted for the Santander X UK Awards 2025! We are incredibly proud to have been selected out of nearly 1,200 applications and to be included in a cohort of entrepreneurs and innovators who are pushing boundaries and building impactful businesses.

Over the coming weeks, we'll be taking part in pitch heats, where we will present Garland Surgical and the to a panel of judges for a chance of securing a place in the National Final on 13 November.

We are looking forward to sharing more about our journey over the coming weeks. If you are curious about the X Awards competition or want to support along the way, stay tuned – we will be posting further updates as the weeks progress.

Thanks to everyone who’s been part of the journey so far and to Santander UK for giving us this opportunity. Let’s see where this next chapter leads… Wish us luck!

13/08/2025

🤩 The votes have been counted.... and we are thrilled to announce that we a finalist for the Life Sciences Innovator of the Year award! 🎉

🙏 Thank you so much for taking the time to vote for us - we are very thankful to each and every one of you.

We now move into the next stage of the competition before the awards ceremony in the autumn where the winner will be announced.

22/07/2025

🌍 "MaltaHip is not just an invention – it is a reinvention of what orthopaedic medicine can achieve. With its roots firmly planted in research from the University of Malta and its branches reaching into global markets, it offers a rare fusion of innovation, inclusivity, and impact."

➡️ Yesterday this article was published on Times² of Malta by THINK Magazine authors. It gives a fantastic synopsis of how the was initially developed through to where we are today.

🙏 We would like to thank all of the authors involved in putting this together!

https://x2.timesofmalta.com/20250721/pink/maltahip-project-whats-next/

What is the MaltaHip Project and how will the team from the University of Malta be changing the lives of millions of peeople with joint-related issues?